Autism spectrum disorder affects 1 in 100 people in the UK, yet treatment options remain limited. Could hyperbaric oxygen therapy (HBOT) offer a complementary approach? This evidence review examines 8+ peer-reviewed studies - including a 2025 meta-analysis of 890 patients - covering what the research shows, protocols studied, safety considerations, and the current NHS and UHMS status. The science is emerging. The evidence is mixed. Here is the full picture.

HBOT wound healing is one of fewer than 15 conditions formally approved by the Undersea and Hyperbaric Medical Society (UHMS) - and one of the only HBOT applications directly commissioned by NHS England. This evidence review examines 18 peer-reviewed studies, outlines the clinical protocols used in research, explains UHMS and NHS approval status, and presents both positive findings and mixed results honestly.

Hyperbaric oxygen therapy (HBOT) reverses biological aging at the cellular level. Israeli research proved that 60 HBOT sessions increase telomere length by 20-38% and reduce senescent cells by 37%. Complete guide to HBOT for longevity, including mechanisms, benefits, protocols, chamber selection, investment analysis, and real-world case studies. Backed by 10 peer-reviewed studies.

Long COVID has disabled millions worldwide. Hyperbaric oxygen therapy (HBOT) delivers measurable improvements in fatigue, brain fog, sleep quality, and mental health—with benefits lasting up to one year. Learn how HBOT works, explore real-world case studies from UK patients, and discover which chamber solution is right for your recovery journey. Evidence-based treatment backed by clinical trials.